NASDAQ : MDXG
MiMedx Group, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 3.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 566.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 478.64M |
| Enterprise Value | 357.84M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 145.93M |
| Shares Outstanding | 145.93M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 1.90% |
| Owned by Institutions (%) | 58.76% |
| Float | 114.95M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| Forward PS | 1.69 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | 25.72 |
| P/OCF Ratio | 23.71 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 19.40 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.35 |
| Quick Ratio | 3.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.93 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -8.53% |
| Return on Assets (ROA) | -5.38% |
| Return on Invested Capital (ROIC) | -26.79% |
| Return on Capital Employed (ROCE) | -11.35% |
| Weighted Average Cost of Capital (WACC) | 10.70% |
| Revenue Per Employee | $375,905 |
| Profits Per Employee | -$23,752 |
| Employee Count | 808 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 2.84 |
Taxes
| Measure | Value |
|---|
| Income Tax | -3.19M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -57.12% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 21.62 |
| Average Volume (20 Days) | 1,670,897 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.26M |
| Short Previous Month | 9.36M |
| Short % of Shares Out | 6.35% |
| Short % of Float | 8.06% |
| Short Ratio (days to cover) | 7.99 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 303.73M |
| Gross Profit | 234.75M |
| Operating Income | -25.14M |
| Pretax Income | -22.38M |
| Net Income | -19.19M |
| EBITDA | -17.31M |
| EBIT | -25.14M |
| Loss Per Share | -$0.13 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 120.79M |
| Total Debt | n/a |
| Net Cash | 120.79M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 211.08M |
| Book Value Per Share | 1.45 |
| Working Capital | 144.20M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 20.74M |
| Capital Expenditures | -1.62M |
| Depreciation & Amortization | 7.83M |
| Net Borrowing | -18.25M |
| Free Cash Flow | 19.12M |
| FCF Per Share | $0.13 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.29% |
| Operating Margin | -8.28% |
| Pretax Margin | -7.37% |
| Profit Margin | -6.32% |
| EBITDA Margin | -5.70% |
| EBIT Margin | -8.28% |
| FCF Margin | 6.30% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.32% |
| Shareholder Yield | 1.32% |
| Earnings Yield | -3.97% |
| FCF Yield | 3.89% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $7.00 |
| Price Target Difference | 113.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -7.07% |
| EPS Growth Forecast (3Y) | -33.89% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 9.44 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |